Autophagic flux disruption is another crucial pathology in TBI mitigated by curcumin treatment via mTOR inhibition and AMPK/ULK1 pathway activation
The two therapies do not share metabolic pathways or compete for the same receptors, so combining them does not create pharmacological conflicts

But during perimenopause and menopause, several critical pathways slow down: Growth hormone (GH) production declines affecting muscle mass, fat metabolism, skin quality, and recovery Inflammatory markers increase contributing to joint pain, brain fog, and metabolic dysfunction Sleep architecture degrades less deep sleep means less cellular repair, less growth hormone release, and more fatigue Collagen synthesis drops dramatically women lose roughly 30% of their collagen in the first five years of menopause, accelerating skin aging, joint stiffness, and connective tissue weakness Gut lining integrity weakens leading to increased inflammation, food sensitivities, and nutrient malabsorption Sexual function changes declining hormones reduce libido, arousal, and tissue health Peptide therapy doesnt replace what menopause takes away it reactivates the pathways that menopause suppresses

Standard supplementation safety guidelines recommend avoiding unstudied supplements during pregnancy unless the clinical benefit clearly outweighs unknown risk
At Bloomsbury Beauty, we utilise glutathione injections for skin brightening, targeting dull, wrinkled, and pigmented skin by reducing melanin production (responsible for our skins pigmentation) and restoring lost tone and glow
Physiological stimulation (such as, for example, physical activity, environmental enrichment, exposure to various diets or even circadian rhythmicity) may significantly change GFAP levels and morphometric parameters of GFAP-positive cellular profiles